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Alendronate decreases urine calcium and supersaturation in genetic mon in patients with calcium nephrolithiasis and contrib-
hypercalciuric rats. utes to UCa oxalate supersaturation and stone formationBackground. The mechanism of excess urine calcium excretion in
[1–3]. There are several mechanisms, alone or in combi-human idiopathic hypercalciuria (IH) has not been determined but
may be secondary to enhanced intestinal calcium absorption, decreased nation, that could be responsible for the increased UCa
renal calcium reabsorption, and/or enhanced bone demineralization. excretion: (a) increased intestinal calcium absorption,We have developed a strain of genetic hypercalciuric stone-forming
either directly or through an increase in the effect of(GHS) rats as an animal model of human IH. When these GHS rats are
placed on a low-calcium diet (LCD), urinary calcium (UCa) excretion 1,25(OH)2D3, (b) decreased renal mineral reabsorption
exceeds dietary calcium intake, suggesting that bone may contribute of either calcium or phosphorus, and/or (c) enhancedto the excess UCa excretion. We used the GHS rats to test the hypothesis
bone resorption [1, 4, 5].that bone contributes to the persistent IH when they are fed an LCD
by determining if alendronate (Aln), which inhibits bone resorption, Hypercalciuria appears spontaneously among rats [6],
would decrease UCa excretion. and mating of spontaneously hypercalciuric rats resultsMethods. GHS rats (N 5 16) and the parent strain (Ctl, N 5 16)
in a successive increase of the IH among their offspringwere fed 13 g/day of a normal (1.2%) calcium diet (NCD) for seven
days and were then switched to a LCD (0.02%) for seven days. Ctl [7–18]. To help understand the mechanism(s) responsi-
and GHS rats in each group were then continued on LCD for an ble for IH in humans, we have established an animaladditional seven days, with or without injection of Aln (50 mg/kg/24
model of IH by inbreeding the most hypercalciuric prog-hrs). UCa excretion was measured daily during the last five days of
each seven-day period. To determine the effects of Aln on urine super- eny of spontaneously hypercalciuric male and female
saturation, the experiment was repeated. All relevant ions were mea- Sprague-Dawley rats [7–16]. Through over 46 genera-sured, and supersaturation with respect to calcium oxalate and calcium
tions of successive inbreeding, we have established ahydrogen phosphate was determined at the end of each period.
Results. UCa was greater in GHS than in Ctl on NCD (7.4 6 0.5 mg/ strain of rats, each of which excrete abnormally large
24 hrs vs. 1.2 6 0.1, GHS vs. Ctl, P , 0.01) and on LCD (3.9 6 0.2 amounts of UCa. The principal mechanism for the exces-mg/24 hrs vs. 0.7 6 0.1, GHS vs. Ctl, P , 0.01). LCD provides 2.6 mg
sive calcium excretion in these rats appears to be anof calcium/24 hrs, indicating that GHS rats are excreting more calcium
than they are consuming. On LCD, Aln caused a significant decrease increase in intestinal calcium absorption [10, 14–16]. The
in UCa in GHS rats and brought GHS UCa well below calcium intake. increased calcium absorption appears to be mediatedAln caused a marked decrease in calcium oxalate and calcium hydrogen
not by an increase in the serum level of 1,25(OH)2D3,phosphate supersaturation.
Conclusion. Thus, on a LCD, there is a significant contribution of but by an increase in the number of intestinal vitamin D
bone calcium to the increased UCa in this model of IH. Aln is effective receptors [15]. When these hypercalciuric rats are fed ain decreasing both UCa and supersaturation. The Aln-induced decrease
very low-calcium diet (LCD), their UCa excretion de-in urine supersaturation should be beneficial in preventing stone forma-
tion in humans, if these results, observed in a short-term study using creases, but remains elevated compared with that of simi-
the hypercalciuric stone-forming rat can be confirmed in longer term larly treated control (Ctl) rats, indicating an additional
human studies.
defect in renal calcium reabsorption and/or an increase
in bone resorption [14]. Many of these hypercalciuric
rats excrete more calcium than they consume, which isExcess urine calcium (UCa) excretion of unknown eti- termed a negative calcium balance [14]. Because theology, so-called idiopathic hypercalciuria (IH), is com-
majority of body calcium is contained within the bone
mineral, the source of the additional UCa may be the
mineral phases of bone [19].Key words: excretion of Ca, bone demineralization, renal stones,
hypercalciuria, bisphosphate, nephrolithiasis. The bone from these hypercalciuric rats releases more
calcium, compared with bone from Ctl rats, when exposedReceived for publication April 13, 1998
to increasing amounts of 1,25(OH)2D3 [11]. In addition, aand in revised form August 10, 1998
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have shown that both the bone and kidney of the hyper- rats received a diet that contained 0.02% calcium, which
was matched to the 1.2% calcium diet. During week 3,calciuric rats also have an increased number of vitamin
D receptors [11, 15]. Thus, these hypercalciuric rats ap- one half of the GHS rats and one half of the Ctl rats,
chosen at random, were given a subcutaneous injectionpear to have a systemic abnormality in calcium homeo-
stasis: they absorb more intestinal calcium; they resorb of Aln 12.5 g/rat/day (approximately 50 mg kg/day) dis-
solved in 100 ml of deionized distilled water. This dosemore bone; and they fail to reabsorb filtered calcium ade-
quately. Because each of these hypercalciuric rats forms of Aln was found to inhibit bone resorption in rats sig-
nificantly [20, 21]. The other half of the GHS and Ctl ratsrenal stones, we have termed the rats genetic hypercalci-
uric stone-forming (GHS) rats [7–10, 12]. Calcium trans- received an injection of only deionized distilled water.
Deionized distilled drinking water was provided ad libi-port abnormalities similar to those documented in the
GHS rats have been observed in patients with IH [2]. tum throughout the course of each study.
In this study, we used the GHS rats to directly test
Urinary calcium excretion study protocolthe hypothesis that bone contributes to the persistent
IH when these rats are fed a LCD and to determine if The GHS rats used for this study were from the 42nd
generation. On days 2 through 7 of each week (week 1,the bone resorption blocker alendronate (Aln) would
alter UCa excretion and urine supersaturation with re- week 2, and week 3), successive 24-hour urine collections
in 0.25 ml 12 n HCl were obtained to measure UCa excre-spect to the solid phases calcium hydrogen phosphate
(brushite) and calcium oxalate (CaOx). We found that tion. The metabolic cages were washed with 1.2 n HCl
between collections to ensure that there was no residualon a LCD there is a significant contribution of bone
calcium to the increased UCa excretion and that Aln is calcium adhering to the stainless steel cages. All urine
samples were refrigerated and measured for calciumeffective in decreasing both UCa excretion and supersatu-
ration. The Aln-induced decrease in urine supersatura- within 48 hours.
tion should be beneficial in preventing stone formation
Urine supersaturation study protocolin humans, if these results, observed in the hypercalciuric
stone-forming rat, can be applied to humans. The GHS rats used for the second study were from
the 46th generation. On days 6 and 7 of each week
(week 1, week 2, and week 3) consecutive 24-hour urine
METHODS
collections were obtained. The first collection was in
Establishment of hypercalciuric rats concentrated HCl and was used to measure oxalate and
citrate. The second collection was in thymol and wasInitially, 20 male and 20 female adult Sprague-Dawley
rats (Charles River Laboratories, Kingston, NY, USA) used for all other determinations [7]. Again, the meta-
bolic cages were washed with 1.2 n HCl between collec-were screened for IH. The rats were placed in individual
metabolic cages and were allowed five days to adjust to tions in order to ensure that there was no residual mate-
rial adhering to the stainless steel cages. All urinethe cage and diet. During this time, the animals were
fed 13 g/day of a diet containing 1.2% calcium, 0.90% samples were stored at 248C, and all measurements were
made within two weeks.phosphorus, 0.24% magnesium, 0.40% sodium, 0.43%
potassium, and 2.2 IU vitamin D3 /gram of food. Deion- Any rat that ate less than 12 g of food or drank less
than 15 ml of water on any day of either study wouldized distilled water was provided ad libitum. Two succes-
sive 24-hour urine collections in 0.25 ml 12 n HCl were have been excluded from the entire study; however, all
rats met this prospective criteria throughout the study.then obtained on days 6 and 7 to measure UCa excretion.
The three male and three female rats with the greatest
Chemical determinationscalcium excretion were used to breed the next genera-
tion. A similar protocol was used to select two to three Calcium was determined by reaction with arsenazo III
and was determined photometrically [22]. Creatinine wasof the most hypercalciuric males and three to four of
the most hypercalciuric females for inbreeding of subse- determined by a modification of the Jaffe method [23].
Inorganic phosphorus was determined by reaction withquent generations [7–16].
ammonium molybdate to form a colored phosphomolyb-
General study protocol date complex [24]. Uric acid was measured after oxidation
by uricase to produce allantoin and hydrogen peroxide.Sixteen female GHS rats and 16 female Sprague-Daw-
ley Ctl rats, each weighing 150 g, were kept in metabolic The hydrogen peroxide reacts with 4-amino-antipyrine
and 3,5-dichloro-2-hydroxybenzene sulfonate in a reac-cages for an additional three weeks. During the first
week, all rats were fed 13 g/day of a normal calcium tion catalyzed by peroxidase to produce a quinoneimine
and was then determined photometrically [25]. Magne-diet (NCD) containing 1.2% calcium, 0.65% phosphorus,
0.24% magnesium, 0.40% sodium, 0.43 potassium, and sium was determined by combination with calmagite and
was measured photometrically [26]. Ammonia was deter-2.2 IU vitamin D3 /g of food. During weeks 2 and 3, the
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mined by coupled enzyme system using glutamate dehy- 5 6 8% (mean 6 sd), respectively [34]. We have used
this computer program previously and found excellentdrogenase and nicotinamide adenine dinucleotide phos-
phate (NADPH) [27]. Sodium was determined by a correspondence between calculated and experimentally
measured saturations in urine and blood [7, 12–14, 38]selective electrode [28] and potassium using a valinomy-
cin membrane attached to a potassium electrode [29]. and in bone culture medium [37, 39].
Chloride was measured coulombmetrically [30]. Oxalic
Statistical analysisacid was measured utilizing oxalate oxidase, which oxi-
dizes oxalate to hydrogen peroxide and carbon dioxide. All values are expressed as mean 6 se. Tests of signifi-
cance were calculated by analysis of variance with theThe hydrogen peroxide then reacts with 3-methly-2-
benzothiazolinone hydrozone and 3-(dimethyl)benzoic Bonferroni correction for multiple comparisons using
conventional computer programs (BMDP; University ofacid to form an indamine dye that is monitored photo-
metrically [31]. Citric acid was determined using citrate California, Los Angeles, CA, USA) on a digital com-
puter. P of less than 0.05 was considered significant.lyase, which catalyzes the conversion citrate to oxalo-
acetic acid and which is then converted to malic acid, in
the presence of malate dehydrogenase. The malic acid
RESULTS
oxidizes NADH to NAD1, which is monitored photo-
Urinary calcium excretion studymetrically [32]. Sulfate concentration was measured by
barium precipitation, monitoring turbidity photometri- During the first week, while eating a normal calcium
diet (NCD) (1.2% Ca), the UCa excretion of the GHScally [33]. pH was measured by an ion-selective electrode.
rats was greater than that of the Ctl rats on each of the
Urine supersaturation five days that urine was collected (P , 0.001, GHS vs.
Ctl on each day, N 5 16 in each group; Fig. 1). DuringThe CaOx ion activity product was calculated using
the computer program EQUIL developed by Finlayson the second week, while eating a low calcium diet (LCD;
0.02% Ca), the UCa of the GHS rats was again signifi-and others [34–36]. The computer program calculates free
ion concentrations using the concentrations of measured cantly greater than that of Ctl rats on each of the five
days that urine was collected (P , 0.001, GHS vs. Ctlligands and known stability constants. Ion activity coef-
ficients are calculated from ionic strength using the Davies on each day, N 5 16 in each group). During the third
week, while eating LCD, the administration of Aln (ap-modification of the Debye-Huckel solution to the Poisson-
Boltzman equation. The program simultaneously solves proximately 50 mg/kg/24 hrs) led to a marked decrease
in UCa in the GHS, but not in the Ctl, rats on each offor all known binding interactions among the measured
substances. Oxalate, phosphorus, and calcium ion activi- the five days that urine was collected (P , 0.001, GHS
vs. GHS 1 Aln on each day, N 5 8 in each group).ties were used to calculate the free-ion activity products.
The free ions in solution are considered to be in an
Urine supersaturation studyequilibrium with the dissolved CaOx governed by a sta-
bility constant (K) of 2.746 3 103 m21 and with the dis- Urinary calcium, magnesium, and phosphorus excre-
tion. As in the UCa excretion study, during the first weeksolved brushite governed by a K of 0.685 3 103 m21. The
value of CaOx in a solution at equilibrium with a solid of the urine supersaturation study, while eating NCD,
UCa of the GHS rats was greater than that of Ctl ratsphase of CaOx, the solubility of CaOx, is 6.16 3 1026 m
per liter. The value of the brushite in a solution at equilib- (P , 0.001, GHS vs. Ctl, N 5 16 in each group; Fig. 2).
Over the second week, while eating LCD, the UCa of therium with a solid phase of brushite, the solubility of
brushite, is 3.981 3 1027 m per liter. The relative supersat- GHS rats was far greater than that of Ctl rats (P , 0.001,
GHS vs. Ctl, N 5 16 in each group). Over the thirduration for CaOx is calculated as the ratio of the free-ion
activity product of calcium and oxalate in the individual week, while eating LCD, Aln (approximately 50 mg/kg/
24 hr) led to a significant decrease in UCa in the GHSurine to the solubility of CaOx. The relative supersatura-
tion for brushite is calculated as the ratio of the free- and in the Ctl rats (P , 0.001, GHS vs. GHS 1 Aln; P ,
0.05, Ctl vs. Ctl 1 Aln, N 5 8 in each group). Urineion activity product of calcium and phosphate in the
individual urine to the solubility of calcium phosphate. magnesium was slightly, but significantly, greater in the
Ctl than in the GHS rats only during week 1 (P , 0.05).Ratios of one connote a sample at equilibrium, above
one supersaturation, and below one undersaturation. There was no difference in magnesium excretion be-
tween any other group throughout the remainder of theThe ability of this computer program to predict accu-
rately the saturation of urine or other solution with re- study, nor was urine Mg excretion affected by Aln in
Ctl or GHS rats. During the first week, while rats werespect to the solid phase is excellent [7, 12–14, 34, 37–39].
With a series of 20 artificial solutions, the equilibrium eating a NCD, there was no difference in phosphorus
excretion between the Ctl and GHS rats; however, urinecalcium concentration and the extent of calcium precipi-
tation were predicted with average errors of 5 6 9% and phosphorus excretion increased in all groups of rats fed
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Fig. 1. Urine calcium excretion study. Daily
urine calcium excretion in genetic hypercalci-
uric stone forming (GHS) and control (Ctl)
rats. During all days of all three weeks, urinary
calcium excretion (UCa) of GHS rats exceeded
Ctl rats on each day (N 5 16 in each group
during weeks 1 and 2, N 5 8 in each group
during week 3). Aln led to a significant de-
crease in UCa in the GHS, but not in the Ctl,
rats (N 5 8 in each group). Abbreviations
and symbols are: GHS, genetic hypercalciuric
stone forming rats (open symbols); Ctl, control
rats (closed symbols); NCD, normal calcium
diet (1.2% calcium, triangles); LCD, low cal-
cium diet (0.02% calcium, squares); LCD 1
Aln, alendronate (,Aln, 50 g/kg/24 hr, circles).
LCD during week 2 and week 3. There was no difference that in the Ctl rats (each P , 0.001, GHS vs. Ctl). During
the third week, while eating LCD, Aln led to a markedin urine phosphorus excretion in any group of rats during
weeks 2 or 3, nor was urine phosphorus excretion af- decrease in both brushite and CaOx supersaturation in
the GHS, but not in the Ctl, rats (each P , 0.001, GHS vs.fected by Aln in Ctl or GHS rats.
Urine oxalate and citrate excretion and pH. Urine oxa- Ctl). With Aln treatment, supersaturation with respect to
late excretion was greater in the Ctl than in the GHS brushite and CaOx in the GHS rats was not different
rats during week 1 (P , 0.05; Fig. 3). There was no from that of Ctl rats.
difference in oxalate excretion between any other group
throughout the remainder of the study, and urine oxalate
DISCUSSIONexcretion was not affected by Aln. During week 1, there
The inbred GHS rats have a marked increase in intesti-was no difference in urine citrate excretion between the
nal calcium absorption accounting for a significant de-GHS and the Ctl rats; however, urine citrate excretion
gree of their IH [10, 14–16]. However, when these ratswas greater in each group of GHS rats compared with
are placed on a LCD, UCa excretion continues to exceedeach group of Ctl rats during week 2 and week 3. Citrate
that of Ctl rats and of dietary calcium intake [14]. Be-excretion was not affected by Aln. During the entire
cause bone contains the majority of total body calciumstudy, the urine pH of each group of GHS rats was less
[40], the source of this additional UCa appears to be thethen the urine pH of each group of Ctl rats during compa-
mineral phases of bone. To directly test the hypothesisrable weeks, and urine pH was not affected by Aln.
that bone allows the IH to persist when the GHS ratsUrine ammonium and creatinine excretion and vol-
are fed a LCD, we used the bone-resorption blockerume. During week 1, there was no difference in urine
Aln [20, 21]. We found that Aln markedly decreases UCaammonium excretion between the GHS and the Ctl rats;
excretion, demonstrating, unequivocally and to our knowl-however, urine ammonium excretion was greater in each
edge for the first time, that bone mineral is the sourcegroup of GHS rats, compared with each group of Ctl
of the additional UCa when the GHS rats are fed a LCD.rats during weeks 2 and 3 (Fig. 4). Ammonium excretion
Supporting a primary role for enhanced bone resorp-was not affected by Aln. There was no difference in urine
tion in maintaining the IH in the GHS rats consumingcreatinine or volume in any group during any period
a LCD is the observation that cultured bone from theseof the study. There was no difference in urine sodium,
rats releases more calcium in response to 1,25(OH)2D3,potassium, or chloride in any group during any period
but not parathyroid hormone (PTH), than bone fromof the study.
Ctl rats [11]. We have previously shown that there areBrushite and CaOx supersaturation. During the first
an increased number of vitamin D receptors in the boneweek, when rats were fed a NCD, urine supersaturation
from the GHS rats [11]. A LCD leads to an increase inwith respect to both brushite (CaHPO4) and CaOx was
1,25(OH)2D3 in normal [4, 41] and GHS [14] rats.greater in the GHS rats than in Ctl rats (each P , 0.001,
Perhaps the increase in vitamin D receptor number re-GHS vs. Ctl; Fig. 5). During the second week, when rats
sults in a greater resorptive effect of the increasedwere fed LCD, urine supersaturation with respect to
both brushite and CaOx in the GHS continued to exceed 1,25(OH)2D3 on bone from the GHS rats.
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Fig. 2. Urine supersaturation study. Urine
calcium, magnesium and phosphorus excre-
tion in genetic hypercalciuric stone forming
and control rats. During all three weeks, UCa
of GHS rats exceeded that of Ctl rats (N 5
16 during weeks 1 and 2 and N 5 8 during
week 3). Aln decreased UCa in both Ctl and
GHS rats. Urine magnesium excretion was
greater in Ctl than in GHS rats only during
week one and was not affected by Aln. During
the first week there was no difference in phos-
phorus excretion between the Ctl and GHS
rats and urine phosphorus excretion increased
in all groups with LCD and was not affected
by Aln. Abbreviations: Ctl, control rats; GHS,
genetic hypercalciuric stone forming rats;
NCD, normal calcium diet (1.2% calcium);
LCD, low calcium diet (0.02% calcium); Aln,
(alendronate, < 50 g/kg/24 hr); *P , 0.05 vs.
same week Ctl; oP , 0.05 vs. Ctl 1 Aln; 1P ,
0.05 vs. same week GHS.
Although this experiment localizes bone as the source show that at the same filtered load of calcium, the GHS
rats excrete far more calcium than Ctls, indicating dimin-of the additional urinary calcium, it does not help to
discriminate definitively as to whether the persistence of ished renal calcium reabsorption in these rats [9]. On a
LCD, the defect in renal calcium reabsorption would leadthe IH in the GHS rats on a LCD is from a primary defect
in renal tubular calcium resorption or from a primary in- to a subtle fall in total and ionized calcium, which would
result in an increase in PTH and 1,25(OH)2D3 [4, 41].crease in bone calcium resorption. The reason for this con-
tinued uncertainty is that clearance studies were used to The increased PTH and 1,25(OH)2D3 would stimulate
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Fig. 3. Urine supersaturation study. Urine
oxalate and citrate excretion and pH in genetic
hypercalciuric stone forming and control rats.
Urine oxalate excretion was greater in the Ctl
than in the GHS rats only during week one
and urine oxalate excretion was not affected
by Aln. During week one there was no differ-
ence in urine citrate excretion between the
GHS and the Ctl rats; however, urine citrate
excretion was greater in each group of GHS,
compared to each group of Ctl, rats during
week two and during week three. Aln did not
affect urine citrate excretion. During the en-
tire study, the urine pH of each group of GHS
rats was less than the urine pH of each group
of Ctl rats during comparable weeks. Urine
pH fell with Aln in the GHS rats. Abbrevia-
tions are: Ctl, control rats; GHS, genetic hy-
percalciuric stone forming rats; NCD, normal
calcium diet (1.2% calcium); LCD, low cal-
cium diet (0.02% calcium); Aln, alendronate
(< 50 g/kg/24 hr); *P , 0.05 vs. same week
Ctl; oP , 0.05 vs. Ctl 1 Aln.
bone resorption leading to maintenance of the IH at the Previously, we have measured serum calcium and
1,25(OH)2D3 in the GHS rats fed a LCD [14]. When fedexpense of the bone mineral. Alternatively, the bone from
the GHS rats could be undergoing direct enhanced re- a LCD, there was no difference in serum calcium be-
tween the Ctl and hypercalciuric rats. However, we foundsorption leading to maintenance of the IH, again at the
expense of the bone mineral content. This latter mecha- that in both the Ctl and GHS rats, serum 1,25(OH)2D3
increased in response to the LCD; however, 1,25(OH)2D3nism would result in a fall in PTH and 1,25(OH)2D3
[4, 41]. In either case, the bone-resorption blocker Aln in the GHS rats did not increase to the same extent as
the Ctls. In spite of a lower 1,25(OH)2D3 in the GHS rats,would decrease UCa excretion.
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Fig. 4. Urine supersaturation study. Urine
ammonium and creatinine excretion and vol-
ume in genetic hypercalciuric stone forming
and control rats. During week one there was
no difference in urine ammonium excretion
between the GHS and the Ctl rats; however,
urine ammonium excretion was greater in
each group of GHS, compared to each group
of Ctl, rats during week two and during week
three. Aln did not affect urine ammonium
excretion. During the entire study, there was
no difference in urine creatinine excretion or
volume in any group of rats. Abbreviations
are: Ctl, control rats; GHS, genetic hypercalci-
uric stone forming rats; NCD, normal calcium
diet (1.2% calcium); LCD, low calcium diet
(0.02% calcium); Aln, alendronate, < 50 g/
kg/24 hr. *P , 0.05 vs. same week Ctl; oP ,
0.05 vs. Ctl 1 Aln.
their intestinal calcium transport increased to a greater rats [8]. Further studies using the GHS rats will be neces-
sary to dissect the regulatory pathways that are responsibleextent. We have previously found that the intestine of
the GHS rat has an increased number of vitamin D for the IH and its persistence when rats are fed a LCD.
The marked fall in the supersaturation of both CaOxreceptors compared with similarly treated Ctl rats [15].
Perhaps the greater receptor number led to a marked and calcium hydrogen phosphate with Aln in the GHS
rats would be expected to result in a decrease in the rateincrease in the effect of 1,25(OH)2D3 on intestinal trans-
port in the GHS rats. In addition, we have recently shown and magnitude of stone formation in these rats [7, 10,
12]. We did not examine stone formation in this short-that 1,25(OH)2D3 induces a greater up-regulation of vita-
min D receptor expression in GHS compared with Ctl term study, as we have previously shown that after six
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Fig. 5. Urine supersaturation study. Brushite
and calcium oxalate supersaturation. During
the entire study urine supersaturation with
respect to both brushite (CaHPO4) and cal-
cium oxalate (CaOx) were both greater in the
GHS rats than in Ctl rats. Aln led to a marked
decrease in both brushite and calcium oxalate
supersaturation in the GHS, but not in the
Ctl, rats. With Aln treatment supersaturation
with respect to both brushite and calcium oxa-
late was decreased such that supersaturation
was not different from that of Ctl rats, with
or without Aln. Abbreviations are: Ctl, con-
trol rats; GHS, genetic hypercalciuric stone
forming rats; NCD, normal calcium diet (1.2%
calcium); LCD, low calcium diet (0.02% cal-
cium); Aln, alendronate < 50 g/kg/24 hr; *P ,
0.05 vs. same week Ctl; oP , 0.05 vs. Ctl 1
Aln; 1P , 0.05 vs. same week GHS.
weeks, only one of six GHS rats has demonstrable stone the GHS and the Ctl rats increased when the rats were
placed on the LCD. This may be due to the decreaseformation and that 18 weeks are required for all GHS
rats to form stones [12]. Further long-term studies, per- in dietary calcium resulting in less binding of intestinal
phosphate, allowing more phosphate to be absorbed andhaps using a longer acting bisphosphonate, will be re-
quired to determine if bone-resorption blockade will de- subsequently excreted [42] or as a consequence of the
LCD-induced increase in 1,25(OH)2D3-stimulating intes-crease the universal stone formation in these rats.
In both experiments reported here, the UCa excretion tinal phosphorus absorption [41]. As Aln decreases UCa
excretion in the GHS rats fed a LCD, it may have beenin the GHS rats fell significantly with Aln, but to a level
that remained greater than that of Ctl rats, with or with- expected to decrease urine phosphorus as well because
bone is composed of calcium phosphorus crystals. How-out Aln (Figs. 1 and 2). This observation suggests that
the increased intestinal calcium absorption in the GHS ever, the magnitude of urine phosphorus excretion is far
greater than UCa excretion (Fig. 2) so that a difference,rats [10, 14–16] in conjunction with their decreased renal
tubular calcium reabsorption [9] allowed some degree if present, would be difficult to observe. It is unclear why
the urine pH is slightly, but significantly, decreased inof IH to persist, as UCa excretion was now below the
level of dietary calcium intake (2.6 mg/24 hr). Alterna- the GHS rats compared with the Ctl rats on all diets and
why urinary citrate excretion is increased in the GHStively, there may have been a persistence of bone resorp-
tion in spite of the substantial dose of Aln or perhaps rats fed a LCD. The GHS and Ctl rats consumed the
same amount of the same diet so that endogenous acidthere was additional physicochemical bone mineral dis-
solution. Careful pathological studies of the bone from production should be similar in both groups of animals.
More acidic urine in the GHS rats may have resultedGHS rats treated with long-term bisphosphonates will
help to determine why the IH persisted during Aln treat- from an increased ability to excrete acid resulting in
relative alkalosis in the Ctl rats and higher citrate excre-ment.
In this study, the urine phosphorus excretion in both tion [2]. Further studies, perhaps using clearance and/or
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2. Asplin JR, Favus MJ, Coe FL: Nephrolithiasis, in The Kidney,microperfusion techniques to study acid transport, will
edited by Brenner BM, Philadelphia, W.B. Saunders Company,
be necessary to determine if there are differences in 1996, p 1893
3. Bushinsky DA: Renal lithiasis, in Kelly’s Textbook of Medicine,tubular acid secretion between the GHS and the Ctl rats.
edited by Kelly WF, New York, J.B. Lippincott, 1996, p 1024The decrease in UCa with Aln is probably not due to 4. Bushinsky DA, Krieger NS: Integration of calcium metabolism
alterations in renal calcium handling, as the bisphospho- in the adult, in Disorders of Bone and Mineral Metabolism, edited
by Coe FL, Favus MJ, New York, Raven Press, 1992, p 417nates appear to inhibit bone resorption specifically [20,
5. Monk RD, Bushinsky DA: Pathogenesis of idiopathic hypercalci-21]. In addition, there was far less of a decrease in renal
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